1. MEK/ERK and PI3K/AKT pathway inhibitors affect the transformation of myelodysplastic syndrome into acute myeloid leukemia via H3K27me3 methylases and de‑methylases
   Zhuanzhen Zheng et al, 2023, International Journal of Oncology CrossRef
2. Inhibition of PI3K-AKT-mTOR pathway and modulation of histone deacetylase enzymes reduce the growth of acute myeloid leukemia cells
   Merve Şansaçar et al, 2023, Medical Oncology CrossRef